ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Karuna Therapeutics, Inc.
NEW YORK, Dec. 22, 2023 /PRNewswire/ — Rowley Law PLLC is investigating potential securities law violations by Karuna Therapeutics, Inc. (NASDAQ: KRTX) and its board of directors concerning the proposed acquisition of the company by Bristol Myers Squibb (NYSE: BMY). Stockholders will receive $330.00 for each share of Karuna Therapeutics stock that they hold. The transaction is valued at approximately $14 billion and is expected to close in the first half of 2024.
Related news for (KRTX)
- SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CVLY, PGTI, KRTX
- SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates KRTX, RYZB, VIA
- SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates ICVX, CVLY, PGTI, KRTX
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RYZB, KRTX, GRCL
- KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. – KRTX